Successful canakinumab treatment for activated innate response in idiopathic Castleman's disease with multiple heterozygous MEFV exon 2 variants

Authors :: Tomohiro Koga
Atsushi Kawakami
Kaori Furukawa
Masataka Umeda
Yushiro Endo
Motoi Takenaka
Source :: Clinical Immunology. 219:108547
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: business.industry
Immunology
Familial Mediterranean fever
Disease
medicine.disease
MEFV
Canakinumab
Exon
Innate response
Immunology and Allergy
Medicine
business
medicine.drug

Full Text Access

Tools